Top Markets
#1 Islamic Coin Islamic Coin +155.98%
#2 Siren Siren +36.71%
#3 Arowana Arowana +21.49%
#4 RedStone RedStone +17.23%
#5 Cysic Cysic +16.87%
#6 Perle Perle +13.35%
#7 Nockchain Nockchain +12.97%
#8 OpenEden OpenEden +12.09%
#9 KUB Coin KUB Coin +11.66%
#10 Venom Venom +11.46%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rank in Stocks #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Share Price
$0.21291741
Last synced: 2025-04-18
Market Cap
$12.07M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
KR
Trade PCL, Inc. (241820)

Category

Healthcare
Number of shares outstanding for PCL, Inc. (241820)
Number of shares outstanding as of September 2025: 2.78M
According to PCL, Inc. latest financial reports and stock price the company's current number of shares outstanding is 2.78M. At the end of December 2023 the company had 40.62M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for PCL, Inc. (241820) from 2015 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.78M -95.05%
2024 56.15M 38.25%
2023 40.62M 14.64%
2022 35.43M 4.04%
2021 34.05M 5.39%
2020 32.31M 6.30%
2019 30.40M 1.18%
2018 30.04M 2.72%
2017 29.25M -2.51%
2016 30.00M 0.00%
2015 30.00M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 1.74B 62,552.16%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 383.50M 13,684.52%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 1.28B 45,983.78%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 1.48B 53,010.83%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 576.40M 20,618.11%
US